Anupam Rasayan to Acquire Jayhawk Fine Chemicals for $150 Million
Anupam Rasayan to acquire Jayhawk Fine Chemicals for $150M (₹1,245 crore), expanding its US presence and polymer portfolio. The acquisition will be funded via internal accruals, debt, and quasi equity.
The acquisition of Jayhawk Fine Chemicals for $150 million (₹1,245 crore) is a significant strategic move for Anupam Rasayan, providing access to the U.S. market and expanding its capabilities in performance materials. This is likely to have a substantial impact on the company's future growth and profitability.
The announcement highlights a strategic acquisition that expands Anupam Rasayan's global presence and product portfolio, which is generally viewed positively by investors.
* Anupam Rasayan India Ltd. has signed a definitive agreement to acquire 100% equity stake in Jayhawk Fine Chemicals Corporation, a U.S. based specialty chemical company, for a purchase consideration of ~$150 million (₹1,245 crore). * The purchase consideration includes payment against the equity value of Jayhawk and existing loans payable to the exiting shareholders. * Factoring in ~$16 million (₹132.8 crore) of cash and cash-like items for Jayhawk as of June-25, the enterprise value translates to ~$134 million (₹1,111.7 crore). * Jayhawk recorded revenues and adjusted EBITDA of ~$78 million (₹646.4 crore) and ~$15 million (₹124.5 crore) respectively in CY24, resulting in an EV to EBITDA multiple of ~9x. * The acquisition will be financed through internal accruals, debt, and quasi equity from a leading global investment management firm with AUM exceeding $100 billion (₹8,30,000 crore). * This acquisition marks Anupam’s entry into onshore manufacturing in the United States, aligning perfectly with the Company’s global expansion strategy. * According to Anand Desai, Managing Director, Anupam Rasayan India Ltd., this acquisition is a transformative step in Anupam’s global journey and strengthens their global footprint.
What to do with a filing like this
Anupam Rasayan India Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Anupam Rasayan India Limited. Read the original for the full detail.